Tazolol
Chemical compound
- none
- 39832-48-9
- 71721
- 64770
- B64Q38TX4G
- Interactive image
- CC(C)NCC(COC1=NC=CS1)O
Tazolol is a beta blocker with some utility in the treatment of heart disease.[1]
See also
- Timolol
- Niridazole
- Fenclozic acid
References
- ^ Strosberg AM (August 1976). "The cardiovascular pharmacology and hemodynamic activity of tazolol, a selective myocardial beta-stimulant". Archives Internationales de Pharmacodynamie et de Therapie. 222 (2): 200–15. PMID 010864.
- v
- t
- e
(antagonize α-adrenergic
vasoconstriction)
Central |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Peripheral |
|
Serotonin receptor antagonists | |
---|---|
Endothelin receptor antagonists (for PHTooltip Pulmonary hypertension) |
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e